Iron(II)-catalysed tyrosinase crosslinked hyaluronic acid hydrogel for the controlled release of human antibodies
Jazyk angličtina Země Velká Británie, Anglie Médium electronic
Typ dokumentu časopisecké články
PubMed
40395034
DOI
10.1039/d4tb02606c
Knihovny.cz E-zdroje
- MeSH
- hydrogely * chemie metabolismus MeSH
- koncentrace vodíkových iontů MeSH
- kyselina hyaluronová * chemie metabolismus MeSH
- léky s prodlouženým účinkem chemie MeSH
- lidé MeSH
- reagencia zkříženě vázaná chemie MeSH
- tyrosinasa * metabolismus chemie MeSH
- uvolňování léčiv MeSH
- železo * chemie metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- hydrogely * MeSH
- kyselina hyaluronová * MeSH
- léky s prodlouženým účinkem MeSH
- reagencia zkříženě vázaná MeSH
- tyrosinasa * MeSH
- železo * MeSH
Tyrosinase is a common crosslinker used in the formation of in situ hydrogels, often resulting in significantly longer gelation times. The rate-determining step for the interconversion between the four discrete states of the enzyme is characterized by a lag phase, which contributes to its slow gelation kinetics. In this study, we report, for the first time, the use of a catalytic amount of iron(II) to produce fast in situ-gellable tyramine-conjugated hyaluronic acid hydrogels (HATA), which are prospectively applicable for nasal drug delivery. We observed gelation times ranging from 886 to 538 seconds, depending on the polymer and enzyme concentrations, irrespective of the pH level tested. The presence of iron(II) significantly reduced the gelation time by an order of magnitude, ranging from 86 seconds to 25.46 seconds, depending on the polymer concentration, pH, and enzyme activity. Based on our findings, we propose a double crosslinking mechanism involving catechol-catechol coupling and catechol-iron(II) complex formation, as evidenced by improvements in the rheological properties of the hydrogels. These novel hydrogels can encapsulate antibodies and provide prolonged release for up to two weeks. Additionally, we confirmed that the crosslinking chemistry did not affect the bioactivity of the antibodies. Given their improved mucoadhesive properties, we envision these hydrogels as promising candidates for the formulation of bioadhesive drug delivery systems.
Contipro a s Dolní Dobrouč 401 56102 Dolní Dobrouč Czech Republic
Department of Biomedical Research University of Bern 3010 Bern Switzerland
Department of Molecular Medicine Faculty of Medicine Laval University Quebec City Qc Canada
Experimental Neurology Center Bern University Hospital University of Bern 3010 Bern Switzerland
Graduate School for Cellular and Biomedical Sciences University of Bern 3010 Bern Switzerland
Citace poskytuje Crossref.org